Lensar (LNSR) Change in Accured Expenses (2019 - 2026)
Lensar (LNSR) reported Change in Accured Expenses of -$3.9 million for Q1 2026, down 3853.4% year-over-year from $103000.0 in Q1 2025, and down 170.73% on a QoQ basis from -$1.4 million in Q4 2025.
Lensar (LNSR) has 8 years of Change in Accured Expenses data on file, last reported at -$3.9 million in Q1 2026.
- Quarterly Change in Accured Expenses fell 3853.4% year-over-year to -$3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.3 million (down 253.22% YoY) and the FY2025 annual result came in at -$341000.0, down 127.97% from the prior year.
- Change in Accured Expenses eased to -$3.9 million in Q1 2026 per LNSR's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.2 million in Q3 2025 and bottomed at -$3.9 million in Q1 2026.
- The 5-year median for Change in Accured Expenses is $165000.0 (2024), against an average of -$117647.1.
- The widest annual swing landed in 2024, when Change in Accured Expenses surged 278.57%; it then sank 3853.4% in 2026.
- Tracing LNSR's Change in Accured Expenses over 5 years: stood at -$266000.0 in 2022, then surged by 200.0% to $266000.0 in 2023, then surged by 278.57% to $1.0 million in 2024, then plunged by 241.81% to -$1.4 million in 2025, then tumbled by 170.73% to -$3.9 million in 2026.
- Per Business Quant, the three latest LNSR Change in Accured Expenses figures stand at -$3.9 million (Q1 2026), -$1.4 million (Q4 2025), and $2.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | -3.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.87 Mn |
| Mar 31, 2026 | -3.87 Mn |
| Dec 31, 2025 | -1.43 Mn |
| Dec 31, 2025 | -1.43 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | -1.18 Mn |
| Jun 30, 2025 | -1.18 Mn |
| Mar 31, 2025 | 103,000.00 |
| Mar 31, 2025 | 103,000.00 |
| Dec 31, 2024 | 1.01 Mn |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 165,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Mar 31, 2024 | -1.49 Mn |
| Mar 31, 2024 | -1.49 Mn |
| Dec 31, 2023 | 266,000.00 |
| Dec 31, 2023 | 266,000.00 |
| Sep 30, 2023 | 1.29 Mn |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 529,000.00 |
| Jun 30, 2023 | 529,000.00 |
| Mar 31, 2023 | -1.20 Mn |
| Mar 31, 2023 | -1.20 Mn |
| Dec 31, 2022 | -266,000.00 |
| Dec 31, 2022 | -266,000.00 |
| Sep 30, 2022 | 594,000.00 |
| Sep 30, 2022 | 594,000.00 |
| Jun 30, 2022 | 966,000.00 |
| Jun 30, 2022 | 966,000.00 |
| Mar 31, 2022 | -1.20 Mn |
| Mar 31, 2022 | -1.20 Mn |
| Dec 31, 2021 | 399,000.00 |
| Dec 31, 2021 | 399,000.00 |
| Sep 30, 2021 | 912,000.00 |
| Sep 30, 2021 | 912,000.00 |
| Jun 30, 2021 | 592,000.00 |
| Jun 30, 2021 | 592,000.00 |
| Mar 31, 2021 | -1.83 Mn |
| Mar 31, 2021 | -1.83 Mn |
| Dec 31, 2020 | 941,000.00 |
| Dec 31, 2020 | 941,000.00 |
| Sep 30, 2020 | 671,000.00 |
| Sep 30, 2020 | 671,000.00 |
| Jun 30, 2020 | 885,000.00 |
| Jun 30, 2020 | 885,000.00 |
| Mar 31, 2020 | -1.63 Mn |
| Mar 31, 2020 | -1.63 Mn |
| Dec 31, 2019 | 1.23 Mn |
| Dec 31, 2019 | 1.23 Mn |